Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neuroectodermal Tumors, Primitive 1Medulloblastoma 1Carcinoma, Squamous Cell 1Brain Neoplasms 1

Interventions

Lomustine 2Gefitinib 2Carboplatin 2trofosfamide 1tozuleristide 1entrectinib 1Vincristine 1Thiotepa 1Temozolomide 1Sunitinib 1Radiotherapy 1Methylprednisolone 1Maintenance Chemotherapy 1Magnetic Resonance Spectroscopy 1Induction Chemotherapy 1Etoposide 1Erlotinib Hydrochloride 1Diploidy 1Dexamethasone 1Cyclophosphamide 1Cisplatin 1Cholecalciferol 1Bevacizumab 1Adrenal Cortex Hormones 1AZD3759 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Brain Neoplasms × Induction Chemotherapy × Clear all
NCT02066220 2025-12-04

International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma

Universitätsklinikum Hamburg-Eppendorf

Phase 2/3 Active not recruiting
360 enrolled
CNS

Brain Neoplasms, Medulloblastoma, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡